Shell Asset Management’s Novavax NVAX Stock Holding History

Shell Asset Management’s Portfolio NVAX Stock Details NVAX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-1,983	Closed	-$146K	–	1423
2022 Q1	$146K	Hold	1,983	–	–	﹤0.01%	1230
2021 Q4	$284K	Buy	1,983 +586	+42%	+$101K	0.01%	1117
2021 Q3	$290K	Sell	1,397 -322	-19%	-$71K	0.01%	1092
2021 Q2	$365K	Sell	1,719 -2,406	-58%	-$441K	0.01%	1050
2021 Q1	$748K	Sell	4,125 -1,522	-27%	-$303K	0.02%	659
2020 Q4	$630K	Hold	5,647	–	–	0.01%	688
2020 Q3	$612K	Buy	5,647 +867	+18%	+$106K	0.01%	594
2020 Q2	$398K	Buy	+4,780	New	+$183K	0.01%	764

Other funds holding NVAX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Coatue Management New York $29.1B AUM 96.54% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Voloridge Investment Management Jupiter, Florida $25B AUM 28.08% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Shell Asset Management's NVAX Position: Q2 2022 in Review

Shell Asset Management sold out of Novavax (NVAX) in Q2 2022, closing a stake of 1,983 shares — an estimated $146K sold.

Shell Asset Management first reported a position in NVAX in Q2 2020 and held it in 8 quarters. The position peaked at $748K in Q1 2021. 325 funds tracked by Wall St. Rank hold NVAX as of Q2 2022.

Shell Asset Management reported no remaining Novavax position as of Q2 2022 after selling out during the quarter.
Shell Asset Management sold 1,983 Novavax shares in Q2 2022, an estimated $146K.
Shell Asset Management first reported a position in Novavax in Q2 2020 and held it in 8 quarters.
Shell Asset Management's Novavax position peaked at $748K in Q1 2021.
325 funds tracked by Wall St. Rank held Novavax as of Q2 2022.

Based on Shell Asset Management's 13F filing for Q2 2022, filed 9 Aug 2022.